Publications

  • Entry multiples hit record highs

    February 28, 2017 | Private Equity | Private Equity International | Media mention

    Entry valuations of 10x earnings during 2016 exceeded crisis levels, but leverage and capital invested is still down on previous highs, says Bain & Company. Hugh MacArthur, a partner with Bain and the head of the firm's global private equity practice, said that the consequence of rising prices is

  • Term Sheet: Private Equity

    February 28, 2017 | Private Equity | Fortune | Media mention

    A new Bain & Company report says that buyout firms' share of M&A deals is at its lowest since 2009, with just 4.2% of deals coming from buyout shops last year. (The peak was 7.9% in 2006.)

  • Global Private Equity Report 2017

    February 27, 2017 | Bain report

    Bain's annual Global Private Equity Report highlights how leading PE firms have begun adapting to a demanding environment.

  • 'Superabundance' of capital causes headaches for PE

    February 27, 2017 | Private Equity | Private Equity International | Media mention

    Deal and exit value fell last year, while the mountain of un-deployed capital – dry powder – hit a record high, according to Bain & Company. “Capital superabundance and the tide of recent exits drove dry powder to yet another record high in 2016,” said Hugh MacArthur, partner and head of Bain's

  • Private equity groups lose out to strategic buyers

    February 27, 2017 | Private Equity | Financial Times | Media mention

    Private equity groups are losing fierce bidding wars for hot targets to cash-rich strategic buyers, driving down the share of deals involving buyout groups to the lowest level since 2009, according to a new analysis from Bain & Company. Hugh MacArthur, a partner with Bain, said companies are also

  • Health-Care Investors Brace for New Wave of Regulatory Change

    February 27, 2017 | Healthcare | WSJ Pro | Media mention

    Joshua Weisbrod, a partner with Bain & Company, said the industry was wrestling with uncertainty even prior to the election. Potential legislative and regulatory actions on drug pricing, the outcomes of payer consolidation efforts and the viability of, and possible changes to, public exchanges were

  • Dry powder hits new record high as private equity continues to outperform, but competition for assets will require added skill to source deals and create value

    February 27, 2017 | Private Equity | Press release

    According to Bain & Company’s eighth annual private equity report, firms have to get smarter about how to differentiate themselves in a challenging fund-raising environment

  • A Smarter Approach to Procurement

    February 24, 2017 | IndustryWeek

    Successful companies achieve greater savings by creating a collaborative partnership between procurement and the business.

  • Teaching old dogs new tricks: Winning in the age of superabundant capital requires a fundamental shift in business strategy and financial management

    February 23, 2017 | Macro Trends | Press release

    In today’s low-cost capital environment, accelerating a company’s growth is nearly four times more valuable than increasing its operating margins, according to Bain & Company

  • How Top Chemical Companies Navigate Portfolio Decisions

    February 22, 2017 | Bain Brief

    Bain research shows that at top chemical companies, greater portfolio coherence leads to higher financial returns.